113 related articles for article (PubMed ID: 23780739)
1. E-64c-hydrazide: a lead structure for the development of irreversible cathepsin C inhibitors.
Radzey H; Rethmeier M; Klimpel D; Grundhuber M; Sommerhoff CP; Schaschke N
ChemMedChem; 2013 Aug; 8(8):1314-21. PubMed ID: 23780739
[TBL] [Abstract][Full Text] [Related]
2. E-64c-Hydrazide Based Cathepsin C Inhibitors: Optimizing the Interactions with the S1'-S2' Area.
Tromsdorf N; Ullrich FTH; Rethmeier M; Sommerhoff CP; Schaschke N
ChemMedChem; 2023 Sep; 18(18):e202300218. PubMed ID: 37424408
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
5. Identification of acridinyl hydrazides as potent aspartic protease inhibitors.
Azim MK; Ahmed W; Khan IA; Rao NA; Khan KM
Bioorg Med Chem Lett; 2008 May; 18(9):3011-5. PubMed ID: 18417344
[TBL] [Abstract][Full Text] [Related]
6. Azapeptides as inhibitors and active site titrants for cysteine proteinases.
Xing R; Hanzlik RP
J Med Chem; 1998 Apr; 41(8):1344-51. PubMed ID: 9548822
[TBL] [Abstract][Full Text] [Related]
7. Design and evaluation of inhibitors for dipeptidyl peptidase I (Cathepsin C).
Kam CM; Götz MG; Koot G; McGuire M; Thiele D; Hudig D; Powers JC
Arch Biochem Biophys; 2004 Jul; 427(2):123-34. PubMed ID: 15196986
[TBL] [Abstract][Full Text] [Related]
8. Interdependency of sequence and positional specificities for cysteine proteases of the papain family.
Nägler DK; Tam W; Storer AC; Krupa JC; Mort JS; Ménard R
Biochemistry; 1999 Apr; 38(15):4868-74. PubMed ID: 10200176
[TBL] [Abstract][Full Text] [Related]
9. Novel semicarbazide-derived inhibitors of human dipeptidyl peptidase I (hDPPI).
Bondebjerg J; Fuglsang H; Valeur KR; Kaznelson DW; Hansen JA; Pedersen RO; Krogh BO; Jensen BS; Lauritzen C; Petersen G; Pedersen J; Naerum L
Bioorg Med Chem; 2005 Jul; 13(14):4408-24. PubMed ID: 15893930
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors.
Turk D; Podobnik M; Popovic T; Katunuma N; Bode W; Huber R; Turk V
Biochemistry; 1995 Apr; 34(14):4791-7. PubMed ID: 7718586
[TBL] [Abstract][Full Text] [Related]
11. Homology modeling of gelatinase catalytic domains and docking simulations of novel sulfonamide inhibitors.
Kiyama R; Tamura Y; Watanabe F; Tsuzuki H; Ohtani M; Yodo M
J Med Chem; 1999 May; 42(10):1723-38. PubMed ID: 10346925
[TBL] [Abstract][Full Text] [Related]
12. Distinct properties of prohormone thiol protease (PTP) compared to cathepsins B, L, and H: evidence for PTP as a novel cysteine protease.
Azaryan AV; Hook VY
Arch Biochem Biophys; 1994 Oct; 314(1):171-7. PubMed ID: 7944391
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of inhibition of cathepsin K by potent, selective 1, 5-diacylcarbohydrazides: a new class of mechanism-based inhibitors of thiol proteases.
Bossard MJ; Tomaszek TA; Levy MA; Ijames CF; Huddleston MJ; Briand J; Thompson S; Halpert S; Veber DF; Carr SA; Meek TD; Tew DG
Biochemistry; 1999 Nov; 38(48):15893-902. PubMed ID: 10625455
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of the binding modes of recently launched dipeptidyl peptidase IV inhibitors in the active site.
Nabeno M; Akahoshi F; Kishida H; Miyaguchi I; Tanaka Y; Ishii S; Kadowaki T
Biochem Biophys Res Commun; 2013 May; 434(2):191-6. PubMed ID: 23501107
[TBL] [Abstract][Full Text] [Related]
15. The acylaminoacyl peptidase from Aeropyrum pernix K1 thought to be an exopeptidase displays endopeptidase activity.
Kiss AL; Hornung B; Rádi K; Gengeliczki Z; Sztáray B; Juhász T; Szeltner Z; Harmat V; Polgár L
J Mol Biol; 2007 Apr; 368(2):509-20. PubMed ID: 17350041
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of human procathepsin X: a cysteine protease with the proregion covalently linked to the active site cysteine.
Sivaraman J; Nägler DK; Zhang R; Ménard R; Cygler M
J Mol Biol; 2000 Jan; 295(4):939-51. PubMed ID: 10656802
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of Plasmodium falciparum dipeptidyl aminopeptidase 1.
Wang F; Krai P; Deu E; Bibb B; Lauritzen C; Pedersen J; Bogyo M; Klemba M
Mol Biochem Parasitol; 2011 Jan; 175(1):10-20. PubMed ID: 20833209
[TBL] [Abstract][Full Text] [Related]
18. In vivo inhibition of serine protease processing requires a high fractional inhibition of cathepsin C.
Méthot N; Guay D; Rubin J; Ethier D; Ortega K; Wong S; Normandin D; Beaulieu C; Reddy TJ; Riendeau D; Percival MD
Mol Pharmacol; 2008 Jun; 73(6):1857-65. PubMed ID: 18326050
[TBL] [Abstract][Full Text] [Related]
19. Fluorogenic peptide substrates for carboxydipeptidase activity of cathepsin B.
Stachowiak K; Tokmina M; Karpińska A; Sosnowska R; Wiczk W
Acta Biochim Pol; 2004; 51(1):81-92. PubMed ID: 15094828
[TBL] [Abstract][Full Text] [Related]
20. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
